Skip to main content
. 2020 Jan 28;58(2):e01029-19. doi: 10.1128/JCM.01029-19

TABLE 5.

Agreement of novel multiplex HEV seroassay with selected tests applied in a previous serosurveya

HEV-IgG or total antibody assay No. of samples (n borderline)b HEV multiplex serology
Agreement
Cohens kappa
n %
(i) recomWell HEV IgG 509 (5) 478 93.9 0.75
(ii) Axiom HEV-Ab ELISA 512 (2) 463 90.4 0.73
(iii) recomLine HEV IgG 514 464 90.3 0.58
Axiom ELISA & recomLine IgGc 415 414 99.8 0.99
a

Reported by Krumbholz et al. (37).

b

The numbers of serum samples exclude specimens with borderline values in the former tests, which were excluded from the analysis of agreement with the HEV multiplex serology.

c

Specimens that were concordant by Axiom ELISA and recomLine IgG assays in the previous study.